Equities

Laxapana PLC

LITE.N0000:CSE

Laxapana PLC

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (LKR)16.80
  • Today's Change0.00 / 0.00%
  • Shares traded50.63k
  • 1 Year change+15.86%
  • Beta--
Data delayed at least 15 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of LKR
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments971860
Total Receivables, Net551288481
Total Inventory674188106
Prepaid expenses------
Other current assets, total------
Total current assets1,322495648
Property, plant & equipment, net470357151
Goodwill, net------
Intangibles, net------
Long term investments608138132
Note receivable - long term------
Other long term assets------
Total assets2,4201,000944
LIABILITIES
Accounts payable--016
Accrued expenses----0
Notes payable/short-term debt4900
Current portion long-term debt/capital leases559527.65
Other current liabilities, total20251233
Total current liabilities999303256
Total long term debt1443749
Total debt7528856
Deferred income tax131----
Minority interest------
Other liabilities, total315.774.78
Total liabilities1,305346310
SHAREHOLDERS EQUITY
Common stock546546546
Additional paid-in capital------
Retained earnings (accumulated deficit)56710786
Treasury stock - common------
Unrealized gain (loss)1.111.111.20
Other equity, total------
Total equity1,115655634
Total liabilities & shareholders' equity2,4201,000944
Total common shares outstanding666666
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.